Pancreatic Neuroendocrine Carcinoma — Trials

Pancreatic Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

37 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Alliance for Clinical Trials in Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02108782	Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors	withdrawn	Phase 2	0	Academic and Community Cancer Research UnitedOTHER	0	Jul 19, 2017	clinicaltrials
NCT00227773	Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors	withdrawn	Phase 2	0	Eastern Cooperative Oncology GroupNETWORK	0	Oct 8, 2015	clinicaltrials